GSK
726 hedge funds and large institutions have $8.38B invested in GSK in 2016 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 274 increasing their positions, 251 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 274 | Existing positions reduced: 251
0.16% less ownership
Funds ownership: 3.54% → 3.39% (-0.16%)
4% less capital invested
Capital invested by funds: $8.72B → $8.38B (-$342M)
Holders
726
Holding in Top 10
11
Calls
$133M
Puts
$86.8M
Top Buyers
| 1 | +$90.8M | |
| 2 | +$42.1M | |
| 3 | +$39.7M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$35.2M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$33.2M |
Top Sellers
| 1 | -$129M | |
| 2 | -$127M | |
| 3 | -$112M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$97.2M |
| 5 |
JPMorgan Chase & Co
New York
|
-$83.7M |